{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:05:29Z","timestamp":1789563929524,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770902"],"award-info":[{"award-number":["81770902"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jchromb.2026.125245","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:39:52Z","timestamp":1786322392000},"page":"125245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A validated sensitive LC-MS\/MS method and its application in elucidating the unique ocular pharmacokinetic profile of 0.01% atropine underpinning its clinical utility for myopia"],"prefix":"10.1016","volume":"1282","author":[{"given":"Juan","family":"Yue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaibing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanglei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoujun","family":"Jian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanting","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jchromb.2026.125245_bb0005","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","article-title":"Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050","volume":"123","author":"Holden","year":"2016","journal-title":"Ophthalmology"},{"issue":"7543","key":"10.1016\/j.jchromb.2026.125245_bb0010","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/519276a","article-title":"The myopia boom","volume":"519","author":"Dolgin","year":"2015","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jchromb.2026.125245_bb0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12886-019-1220-0","article-title":"A review on the epidemiology of myopia in school children worldwide","volume":"20","author":"Grzybowski","year":"2020","journal-title":"BMC Ophthalmol."},{"issue":"6","key":"10.1016\/j.jchromb.2026.125245_bb0020","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/APO.0000000000000234","article-title":"Epidemiology of pathologic myopia in Asia and worldwide","volume":"5","author":"Wong","year":"2016","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"4","key":"10.1016\/j.jchromb.2026.125245_bb0025","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1167\/iovs.61.4.49","article-title":"The complications of myopia: a review and Meta-analysis","volume":"61","author":"Haarman","year":"2020","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.jchromb.2026.125245_bb0030","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ophtha.2015.11.010","article-title":"Efficacy comparison of 16 interventions for myopia control in children: a network Meta-analysis","volume":"123","author":"Huang","year":"2016","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.jchromb.2026.125245_bb0035","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/j.ophtha.2006.05.062","article-title":"Atropine for the treatment of childhood myopia","volume":"113","author":"Chua","year":"2006","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.jchromb.2026.125245_bb0040","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","article-title":"Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (atropine for the treatment of myopia 2)","volume":"119","author":"Chia","year":"2012","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.jchromb.2026.125245_bb0045","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1089\/jop.2015.0043","article-title":"Atropine 0.01% eye drops significantly reduce the progression of childhood myopia","volume":"31","author":"Clark","year":"2015","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.jchromb.2026.125245_bb0050","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ophtha.2015.07.004","article-title":"Five-year clinical trial on atropine for the treatment of myopia 2: myopia control with atropine 0.01% eyedrops","volume":"123","author":"Chia","year":"2016","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.jchromb.2026.125245_bb0055","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1089\/jop.2017.0144","article-title":"A review of myopia control with atropine","volume":"34","author":"Tran","year":"2018","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.jchromb.2026.125245_bb0060","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","article-title":"Low-concentration atropine for myopia progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control","volume":"126","author":"Yam","year":"2019","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.jchromb.2026.125245_bb0065","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1001\/jamaophthalmol.2020.3820","article-title":"Safety and efficacy of low-dose atropine eyedrops for the treatment of myopia progression in Chinese children: a randomized clinical trial","volume":"138","author":"Wei","year":"2020","journal-title":"JAMA Ophthalmol."},{"issue":"2","key":"10.1016\/j.jchromb.2026.125245_bb0070","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1111\/aos.13889","article-title":"The penetration and distribution of topical atropine in animal ocular tissues","volume":"97","author":"Wang","year":"2019","journal-title":"Acta Ophthalmol."},{"issue":"1","key":"10.1016\/j.jchromb.2026.125245_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211376","article-title":"MALDI imaging mass spectrometry revealed atropine distribution in the ocular tissues and its transit from anterior to posterior regions in the whole-eye of rabbit after topical administration","volume":"14","author":"Mori","year":"2019","journal-title":"PloS One"},{"issue":"8","key":"10.1016\/j.jchromb.2026.125245_bb0080","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/OPX.0000000000002044","article-title":"Evaluation of the levels of low-dose topical atropine (0.01%) in aqueous and vitreous humor in human eyes","volume":"100","author":"Kumar","year":"2023","journal-title":"Optom. Vis. Sci."},{"issue":"11","key":"10.1016\/j.jchromb.2026.125245_bb0085","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1007\/s11095-021-03135-4","article-title":"Stable atropine loaded film as a potential ocular delivery system for treatment of myopia","volume":"38","author":"Ji","year":"2021","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.jchromb.2026.125245_bb0090","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1208\/s12248-025-01052-7","article-title":"An ocular exposure prediction for topical atropine in human using physiologically based pharmacokinetic modeling","volume":"27","author":"Zheng","year":"2025","journal-title":"AAPS J."},{"issue":"2","key":"10.1016\/j.jchromb.2026.125245_bb0095","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0378-5173(89)90030-6","article-title":"Liposomal ophthalmic drug delivery. III. Pharmacodynamic and biodisposition studies of atropine","volume":"55","author":"Meisner","year":"1989","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jchromb.2026.125245_bb0100","first-page":"464","article-title":"Expression of muscarinic receptor subtypes in tree shrew ocular tissues and their regulation during the development of myopia","volume":"15","author":"McBrien","year":"2009","journal-title":"Mol. Vis."},{"issue":"3","key":"10.1016\/j.jchromb.2026.125245_bb0105","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/ICL.0000000000000677","article-title":"Biological mechanisms of atropine control of myopia","volume":"46","author":"Upadhyay","year":"2020","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.jchromb.2026.125245_bb0110","first-page":"680","article-title":"Molecular mechanisms of muscarinic receptors in mouse scleral fibroblasts: prior to and after induction of experimental myopia with atropine treatment","volume":"17","author":"Barathi","year":"2011","journal-title":"Mol. Vis."},{"key":"10.1016\/j.jchromb.2026.125245_bb0115","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.preteyeres.2017.06.003","article-title":"Dopamine signaling and myopia development: what are the key challenges","volume":"61","author":"Zhou","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jchromb.2026.125245_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.109071","article-title":"Candidate pathways for retina to scleral signaling in refractive eye growth","volume":"219","author":"Brown","year":"2022","journal-title":"Exp. Eye Res."},{"issue":"2","key":"10.1016\/j.jchromb.2026.125245_bb0125","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1034\/j.1600-0420.1999.770215.x","article-title":"Systemic bioavailability of ocularly applied 1% atropine eyedrops","volume":"77","author":"Kaila","year":"1999","journal-title":"Acta Ophthalmol. Scand."},{"issue":"12","key":"10.1016\/j.jchromb.2026.125245_bb0130","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1021\/js9802594","article-title":"Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye","volume":"87","author":"Prausnitz","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jchromb.2026.125245_bb0135","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.addr.2017.12.008","article-title":"Implications of melanin binding in ocular drug delivery","volume":"126","author":"Rimpel\u00e4","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.jchromb.2026.125245_bb0140","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1089\/jop.1994.10.217","article-title":"Relevance of drug-melanin interactions to ocular pharmacology and toxicology","volume":"10","author":"Salazar-Bookaman","year":"1994","journal-title":"J. Ocul. Pharmacol."},{"key":"10.1016\/j.jchromb.2026.125245_bb0145","series-title":"Pharmacology of the Eye","first-page":"19","article-title":"Ocular pharmacokinetics","author":"Maurice","year":"1984"},{"issue":"9","key":"10.1016\/j.jchromb.2026.125245_bb0150","doi-asserted-by":"crossref","first-page":"6124","DOI":"10.1167\/iovs.10-7088","article-title":"Disruption of Emmetropization and high susceptibility to deprivation myopia in albino Guinea pigs","volume":"52","author":"Jiang","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157002322600334X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157002322600334X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:20:50Z","timestamp":1789561250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S157002322600334X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":30,"alternative-id":["S157002322600334X"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2026.125245","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A validated sensitive LC-MS\/MS method and its application in elucidating the unique ocular pharmacokinetic profile of 0.01% atropine underpinning its clinical utility for myopia","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2026.125245","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"125245"}}